A phase I trial of the single-chain immunotoxin SGN-10 (BR96 sFv-PE40) in patients with advanced solid tumors
- James A. Posey
- , Mohammad B. Khazaeli
- , Michael A. Bookman
- , Anahit Nowrouzi
- , William E. Grizzle
- , Jennifer Thornton
- , Delicia E. Carey
- , Jennifer M. Lorenz
- , Amy P. Sing
- , Clay B. Siegall
- , Albert F. LoBuglio
- , Mansoor N. Saleh
Research output: Contribution to journal › Article › peer-review
111
Citations
(Scopus)